Clinical Trial Update: A Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With ITCA 650 [Phase 3]

View source ↗

Summary

This Clinical Trial Update reports that the Phase 3 cardiovascular outcomes study of ITCA 650 in type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• ITCA 650

Snippet

Sponsor: Intarcia Therapeutics | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED